GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Telo Genomics TELO.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.05

—

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Telo Genomics — daily TSXV:TELO Delayed
Market value
C$4.5m
Last close × shares
Volume
10
Shares, 9 Nov 2026

About Telo Genomics

Its shares trade on TSX Venture under the ticker TELO.V. It has been listed since 15 February 2012.

Telo Genomics Corp. is a biotechnology company, which engages in the development and commercialization of technological products designed to personalize treatment plans for patients who have specific conditions. The company is headquartered in Toronto, Ontario. The company went IPO on 2012-02-15. The firm is focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display genomic instability. Its lead product, TeloView SMM, is a high-complexity molecular assay available for clinical use to provide information to physicians treating patients with Smoldering Multiple Myeloma. Through proprietary telomere-based analysis, TeloView SMM selects high-risk SMM patients who are likely to benefit from earlier treatment intervention while identifying the larger subset of low-risk SMM patients who have a more stable form of the disease and do not require immediate treatment. The TeloView SMM assay has a potential total addressable market of over 500,000 tests per year.

Figures and description from our data supplier, not checked against the company's own report.

More about Telo Genomics →

Latest on Telo Genomics

Our reporting

We have not reported on Telo Genomics yet.

Next results

25 Nov 2026

Due on 25 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Telo Genomics's ticker?

Telo Genomics trades as TELO.V on TSX Venture, under ISIN CA87975M2085.

What was Telo Genomics's last closing price?

0.05 on 9 Nov 2026. The figure is in CAD and is never converted.

When does Telo Genomics next report results?

Results are expected on 25 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.